JPMorgan Healthcare Leaders ETF (JDOC)
59.67
+0.38
(+0.65%)
USD |
NASDAQ |
Jan 22, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.65% | -0.04% | 8.956M | 621.53 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 1.29% | 55.00% | -155059.0 | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term capital appreciation. Under normal circumstances, the Fund will primarily invest in the equity securities of Healthcare Companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap Core |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | J.P. Morgan Asset Management |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of January 23, 2026.
Asset Allocation
As of December 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.72% |
| Stock | 98.19% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 1.09% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term capital appreciation. Under normal circumstances, the Fund will primarily invest in the equity securities of Healthcare Companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap Core |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | J.P. Morgan Asset Management |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |